These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9548819)
1. d-Fused [1]benzazepines with selective in vitro antitumor activity: synthesis and structure-activity relationships. Link A; Kunick C J Med Chem; 1998 Apr; 41(8):1299-305. PubMed ID: 9548819 [TBL] [Abstract][Full Text] [Related]
2. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity. Schultz C; Link A; Leost M; Zaharevitz DW; Gussio R; Sausville EA; Meijer L; Kunick C J Med Chem; 1999 Jul; 42(15):2909-19. PubMed ID: 10425100 [TBL] [Abstract][Full Text] [Related]
3. Antitumor pyrido[3,2-d][1]benzazepines: synthesis and in vitro activity of thiophene analogs. Link A; Zaharevitz DW; Kunick C Pharmazie; 1999 Mar; 54(3):163-6. PubMed ID: 10192102 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents. Kock I; Heber D; Weide M; Wolschendorf U; Clement B J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues. Congiu C; Cocco MT; Onnis V Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents. Gangjee A; Adair OO; Queener SF J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957 [TBL] [Abstract][Full Text] [Related]
7. Matrix compare analysis discriminates subtle structural differences in a family of novel antiproliferative agents, diaryl-3-hydroxy-2,3,3a,10a-tetrahydrobenzo[b]cycylopenta[e]azepine-4,10(1H,5H)-diones. Kunick C; Bleeker C; Prühs C; Totzke F; Schächtele C; Kubbutat MH; Link A Bioorg Med Chem Lett; 2006 Apr; 16(8):2148-53. PubMed ID: 16464582 [TBL] [Abstract][Full Text] [Related]
8. Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure--activity relationship studies. Putey A; Popowycz F; Do QT; Bernard P; Talapatra SK; Kozielski F; Galmarini CM; Joseph B J Med Chem; 2009 Oct; 52(19):5916-25. PubMed ID: 19743863 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of paullones with aminoalkyl side chains. Wieking K; Knockaert M; Leost M; Zaharevitz DW; Meijer L; Kunick C Arch Pharm (Weinheim); 2002 Jul; 335(7):311-7. PubMed ID: 12207280 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antitumor activity of novel series 2-benzylthio-4-chlorobenzenesulfonamide derivatives. Sławiński J; Brzozowski Z Eur J Med Chem; 2006 Oct; 41(10):1180-9. PubMed ID: 16777268 [TBL] [Abstract][Full Text] [Related]
11. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines. Gangjee A; Adair O; Queener SF J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo. Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of new 1,3,4-benzotriazepin-5-one derivatives and their biological evaluation as antitumor agents. Taher AT; Mohammed LW Arch Pharm Res; 2013 Jun; 36(6):684-93. PubMed ID: 23504247 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of benzo[3,4]azepino[1,2-b]isoquinolin-9-ones from 3-arylisoquinolines via ring closing metathesis and evaluation of topoisomerase I inhibitory activity, cytotoxicity and docking study. Van HT; Khadka DB; Yang SH; Le TN; Cho SH; Zhao C; Lee IS; Kwon Y; Lee KT; Kim YC; Cho WJ Bioorg Med Chem; 2011 Sep; 19(18):5311-20. PubMed ID: 21873069 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents. Rostom SA; Hassan GS; El-Subbagh HI Arch Pharm (Weinheim); 2009 Oct; 342(10):584-90. PubMed ID: 19714673 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of novel pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-one derivatives. El-Nassan HB Eur J Med Chem; 2011 Jun; 46(6):2031-6. PubMed ID: 21429629 [TBL] [Abstract][Full Text] [Related]
17. Benzimidazole condensed ring systems. XII. Synthesis and anticancer evaluation of certain pyrido[1,2-a]benzimidazole derivatives. el-Hawash SA; Badawey el-S A; Kappe T Pharmazie; 1999 May; 54(5):341-6. PubMed ID: 10368827 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumour activity of a series of cyclic amidines of 2,3-dihydro-1H-1,5-benzodiazepines. Janciene R; Kosychova L; Bukelskiene V; Domkus V; Stumbreviciūte Z; Ragaleviciene V; Puodziūnaite BD Arzneimittelforschung; 2002; 52(6):475-81. PubMed ID: 12109049 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines. Fahmy HT; Rostom SA; Saudi MN; Zjawiony JK; Robins DJ Arch Pharm (Weinheim); 2003 Jul; 336(4-5):216-25. PubMed ID: 12916055 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor evaluation of new polysubstituted thiazole and derived thiazolo[4, 5-d]pyrimidine systems. Fahmy HT; Rostom SA; Bekhit AA Arch Pharm (Weinheim); 2002 May; 335(5):213-22. PubMed ID: 12210778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]